JPS63222113A - Plaster composition - Google Patents
Plaster compositionInfo
- Publication number
- JPS63222113A JPS63222113A JP5604787A JP5604787A JPS63222113A JP S63222113 A JPS63222113 A JP S63222113A JP 5604787 A JP5604787 A JP 5604787A JP 5604787 A JP5604787 A JP 5604787A JP S63222113 A JPS63222113 A JP S63222113A
- Authority
- JP
- Japan
- Prior art keywords
- water
- active ingredient
- composition
- oil
- oily
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 239000011505 plaster Substances 0.000 title abstract description 5
- 239000004480 active ingredient Substances 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000000126 substance Substances 0.000 claims abstract description 10
- 239000003349 gelling agent Substances 0.000 claims description 5
- 239000003921 oil Substances 0.000 abstract description 25
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 13
- 238000010521 absorption reaction Methods 0.000 abstract description 12
- -1 primary alcohol fatty acid Chemical class 0.000 abstract description 10
- 239000003795 chemical substances by application Substances 0.000 abstract description 9
- 239000000377 silicon dioxide Substances 0.000 abstract description 7
- 238000001816 cooling Methods 0.000 abstract description 4
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 4
- 239000000194 fatty acid Substances 0.000 abstract description 4
- 229930195729 fatty acid Natural products 0.000 abstract description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 abstract description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 abstract description 4
- 108010010803 Gelatin Proteins 0.000 abstract description 2
- 229920000159 gelatin Polymers 0.000 abstract description 2
- 239000008273 gelatin Substances 0.000 abstract description 2
- 235000019322 gelatine Nutrition 0.000 abstract description 2
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 2
- 229960000905 indomethacin Drugs 0.000 abstract description 2
- 229960001047 methyl salicylate Drugs 0.000 abstract description 2
- 235000010493 xanthan gum Nutrition 0.000 abstract description 2
- 239000000230 xanthan gum Substances 0.000 abstract description 2
- 229920001285 xanthan gum Polymers 0.000 abstract description 2
- 229940082509 xanthan gum Drugs 0.000 abstract description 2
- 235000019198 oils Nutrition 0.000 abstract 4
- 229920000642 polymer Polymers 0.000 abstract 2
- 239000004372 Polyvinyl alcohol Substances 0.000 abstract 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 235000019477 peppermint oil Nutrition 0.000 abstract 1
- 229920002451 polyvinyl alcohol Polymers 0.000 abstract 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 abstract 1
- 239000011164 primary particle Substances 0.000 abstract 1
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000004745 nonwoven fabric Substances 0.000 description 4
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229960002389 glycol salicylate Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 229940073665 octyldodecyl myristate Drugs 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 238000004026 adhesive bonding Methods 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 229920006255 plastic film Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000007665 sagging Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- TZZAKSLHHIJRLL-UHFFFAOYSA-N 4-hydroxy-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1O TZZAKSLHHIJRLL-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 239000005746 Carboxin Substances 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- GYSSRZJIHXQEHQ-UHFFFAOYSA-N carboxin Chemical compound S1CCOC(C)=C1C(=O)NC1=CC=CC=C1 GYSSRZJIHXQEHQ-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical group COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-M nonanoate Chemical compound CCCCCCCCC([O-])=O FBUKVWPVBMHYJY-UHFFFAOYSA-M 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000011163 secondary particle Substances 0.000 description 1
- 239000002210 silicon-based material Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229920006132 styrene block copolymer Polymers 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は貼付剤組成物、更に詳細には、有効成分の膏体
からの放出性及び経皮吸収性を高めた貼付剤組成物に関
する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a patch composition, and more particularly to a patch composition in which the release of active ingredients from a plaster and the percutaneous absorption thereof are improved.
貼付剤、就中湿布剤、79ツデ剤等の親水性貼付剤は、
肩こり、腰痛、打ち身、捻挫、筋肉痛等の疾患部位に貼
付して用いる外用剤でろる。そして、その効果は、有効
成分による効果のほかに、と九に含まれる水や油による
有効成分の経皮吸収促進効果、水による冷却効果、膏体
等による保護効果によるものと考えられている。Hydrophilic patches such as patches, poultices, and 79 Tsude preparations are:
It is an external preparation that is applied to areas affected by stiff shoulders, lower back pain, bruises, sprains, muscle pain, etc. In addition to the effect of the active ingredients, this effect is thought to be due to the water and oil contained in Toku, which promotes transdermal absorption of the active ingredients, the cooling effect of water, and the protective effect of plasters, etc. .
従来、貼付剤は、一般に、カオリン、メルク、ベントナ
イト、二酸化チタン、酸化亜鉛等の無機粉体を賦形剤と
し、これに水溶性高分子物質:グリセリン、ソルビトー
ル、?リエチレングリコール等の保湿剤;水及び有効成
分を加え練合して得られるペースト状の膏体を紙、織布
、不織布、プラスチックフィルム等の支持体(バッキン
グ)に塗布して調製されている。Conventionally, patches have generally used inorganic powders such as kaolin, Merck, bentonite, titanium dioxide, and zinc oxide as excipients, and water-soluble polymeric substances such as glycerin, sorbitol, etc. Humectants such as lyethylene glycol; prepared by adding and kneading water and active ingredients and applying a paste-like paste to a support (backing) such as paper, woven fabric, non-woven fabric, or plastic film.
ところで、膏体中の水分及び油分は、上述した如く冷却
効果を奏すると共に、有効成分の経皮吸収を高める作用
を有する。By the way, the water and oil content in the paste has a cooling effect as described above, and also has the effect of increasing transdermal absorption of the active ingredient.
しかしながら、従来、貼付剤の膏体中に水分を多く含ん
だ系において安定に含有させることの出来る油分の量に
は制限かぁって、(にしみ出し、ダレの原因となるため
有効成分以外の油分は出来るだけ排除されていた。その
ため、有効成分の膏体からの放出性及び経皮吸収性が充
分でなく、自ずから従来の貼付剤は速効性、持続性に欠
けるという欠点がめった。However, in the past, there was a limit to the amount of oil that could be stably contained in a patch with a high water content (because it could cause oozing and sagging), it was difficult to use oil other than the active ingredient. Oil content was excluded as much as possible.As a result, the release of the active ingredient from the plaster and its transdermal absorption were insufficient, and conventional patches often lacked quick-acting and long-lasting effects.
斯かる実状において、本発明者は鋭意研究を行った結果
、水溶性高分子物質、有効成分以外の油成分(以下、「
油成分」と称することもある)、油性グル化剤及び全組
成の30%以上の水分を配合して調製した貼付側組成物
がしみ出しやブレがなく有効成分の膏体からの放出性及
び経皮吸収性において極めて優れていることを見出し、
本発明を完成した。Under such circumstances, the present inventor conducted intensive research and found that water-soluble polymer substances and oil components other than active ingredients (hereinafter referred to as "
The patch-side composition prepared by blending an oil-based gluing agent (sometimes referred to as "oil component"), and 30% or more water of the total composition has the ability to release the active ingredient from the paste without oozing or blurring. We discovered that it has excellent transdermal absorption.
The invention has been completed.
すなわち、本発明は、水溶性高分子物質1〜30重量%
、有効成分以外の油成分2〜20重量%、水分307E
[t%以上、油性ゲル化剤1〜15重量%及び有効成分
を含有することを特徴とする貼付側組成物を提供するも
のである。That is, in the present invention, 1 to 30% by weight of a water-soluble polymer substance
, oil components other than active ingredients 2 to 20% by weight, moisture 307E
[This invention provides a patch-side composition characterized by containing 1 to 15% by weight of an oil-based gelling agent and an active ingredient.
本発明において、水溶性高分子物質としては、例えばゼ
ラチン、ベクチ/、?リアクリル酸、?リアクリル酸ソ
ーダ、アルギン酸ソーダ、?リピニルアルコール、ポリ
ビニルピロリド/、?リピニルカル4?キシ共重合体、
?リピニルビロリドンΦビニルアセテート共重合体、?
リエチレンオキサイド、カルボキンメチルセルロース、
ヒドロキンメチルセルロース、ヒドロキシエチルセルロ
ース、メチルセルロース、エチルセルロース、キサンタ
ンガム、アラビアガム、トラガントガム、カラヤガム、
メトキシエチレン及び無水マレイン酸共重金物等が挙げ
られ、これらは1種又は2種以上を用いることができる
。これらの水溶性高分子物質は、組成物全体の1〜30
%、好ましくは2〜15%配合される。In the present invention, water-soluble polymeric substances include, for example, gelatin, vector, etc. Lyacrylic acid? Sodium acrylate, sodium alginate? Lipinyl alcohol, polyvinylpyrrolid/? Lipinircal 4? xy copolymer,
? Lipinyl pyrrolidone Φ vinyl acetate copolymer,?
Liethylene oxide, carboxin methylcellulose,
Hydroquine methylcellulose, hydroxyethylcellulose, methylcellulose, ethylcellulose, xanthan gum, gum arabic, gum tragacanth, gum karaya,
Examples include methoxyethylene and maleic anhydride co-heavy metals, and these may be used alone or in combination of two or more. These water-soluble polymer substances account for 1 to 30% of the total composition.
%, preferably 2 to 15%.
油成分としては、例えば−級アルコール脂肪酸エステル
;スクアレン、スクワラン、deす;Ifン、流動、Q
ラフイン等の高級炭化水素;シリコーン油等の含ケイ素
化合物;モノグリセリド、ジグリセリド、トリグリセリ
ド等の脂肪酸グリセリンエステル類等が挙げられる。そ
の中でも、次の一般式%式%
(式中、R1は炭素数2〜18の、島は炭素数1〜18
の直鎖もしくは分岐アルキル基を示す)で表わされる一
級アルコール脂肪酸エステルが好ましく、就中ミリスチ
ン酸イソプロピル、ミリスチン酸オクチルドデシルは当
該放出性、経皮吸収性の向上効果が高く、しかも皮膚刺
激が少ないため特に好ましい。これらの配合量は全組成
の2〜20%、好ましくは2.5〜10%である。Examples of oil components include -grade alcohol fatty acid ester; squalene, squalane, desu;
Examples include higher hydrocarbons such as rough-in; silicon-containing compounds such as silicone oil; and fatty acid glycerin esters such as monoglyceride, diglyceride, and triglyceride. Among them, the following general formula % formula % (in the formula, R1 has 2 to 18 carbon atoms, and the island has 1 to 18 carbon atoms)
Primary alcohol fatty acid esters represented by (representing a straight chain or branched alkyl group) are preferred, and among these, isopropyl myristate and octyldodecyl myristate have a high effect of improving release properties and percutaneous absorption, and are less irritating to the skin. Therefore, it is particularly preferable. The blending amount of these is 2 to 20%, preferably 2.5 to 10% of the total composition.
油性ゲル化剤としては、例えばゾペンゾリデンソルピト
ール、12−ヒドロキシステアリン酸、ステアリン酸金
属塩、アシル化アミノ酸、シリカ剤、エチレンビニルア
セテート共重合体、スチレン−エチレン−フチレンース
チレンフクック共重合体、スチレン−イソプレン−スチ
レンブロック共重合体、スチレンープタゾエンースチレ
ンブロック共重合体等が挙げられる。これらの中でも、
貼付側組成物中の含水量が多いことを考慮すると7リカ
剤が好ましく、そのシリカ剤の中でも無水軽質シリカ、
特に−次粒子の平均径が1〜500mμ、更に好ましく
は5〜100mμのものが好ましい0
この油性グル化剤は、貼付側組成物中の油成分の分散、
均一性を安定化し、油成分のしみ出しを抑える作用を奏
するので、皮膚へのべたつきがない良好な貼付側組成物
が得られる。この油性ゲル化剤の配合量は、全組成の1
〜15%、特に2〜10%が好ましい。Examples of oil-based gelling agents include zopenzolidenesorpitol, 12-hydroxystearic acid, stearic acid metal salts, acylated amino acids, silica agents, ethylene vinyl acetate copolymers, and styrene-ethylene-phthylene-styrene hooks. Examples include copolymers, styrene-isoprene-styrene block copolymers, styrene-ptazoene-styrene block copolymers, and the like. Among these,
Considering the high water content in the patch composition, 7 silica agents are preferred, and among these silica agents, anhydrous light silica,
In particular, it is preferable that the average diameter of the secondary particles is 1 to 500 mμ, more preferably 5 to 100 mμ. This oil-based gluing agent is used to disperse the oil component in the patch-side composition,
Since it has the effect of stabilizing the uniformity and suppressing the seepage of oil components, a good patch-side composition that is not sticky to the skin can be obtained. The amount of this oil-based gelling agent is 1% of the total composition.
~15%, especially 2-10% is preferred.
更に、本発明貼付剤組成物には水分を30%以上配合す
ることが必須でるり、これ未満では本発明の効果は奏さ
れない。特に水分を全組成の40〜75%配合するのが
好ましい。Furthermore, it is essential that the patch composition of the present invention contains 30% or more of water; if it is less than this, the effects of the present invention will not be achieved. In particular, it is preferable to mix water in an amount of 40 to 75% of the total composition.
また、有効成分としては、斯かる場合に一般に使用され
ている、例えばサリチル酸メチル、サリチル酸グリコー
ル、インドメタシン、!−メントール、ハツカ油、ユー
カリ油、dl−カンフルトウガラシエキス、ノニル酸ワ
ニリルアミド、酢酸トコフェロール、ソフエンヒトラミ
ン、マレイン酸りaルフエニラミン、チモール等の1種
又は2種以上が配合される。この配合量は、一般に0.
01〜20%が好ましい。In addition, as active ingredients, commonly used in such cases, for example, methyl salicylate, glycol salicylate, indomethacin, etc. - One or more of menthol, pepper oil, eucalyptus oil, dl-camphor capsicum extract, vanillylamide nonylate, tocopherol acetate, sophenhydramine, alpha maleic acid, thymol, etc. are blended. This amount is generally 0.
01-20% is preferred.
本発明の貼付側組成物には、上記必須成分のほかに、必
要に応じて、貼付剤に一般に使用嘔れている、例えば、
プロピレングリコール、グリセリン、ンルピトール、−
リエテレ/グリコール、乳酸す) +3ウム等の保湿剤
の1種又は2種以上(配合量は通常、組成物全体の5〜
30%);カオリン、メルク、ベントナイト、二酸化チ
タン、酸化亜鉛等の無機粉体の1種又は2種以上(配合
量は通常O〜30%);更に膏体物性(柔軟性、粘着性
、保型性等)の調整を目的とする昶リプテン、アクリル
樹脂エマルション、酢酸ビニルエマルショア等の高分子
物質等を配合することができる。In addition to the above-mentioned essential ingredients, the patch composition of the present invention may optionally contain ingredients commonly used in patches, such as:
Propylene glycol, glycerin, lupitor, -
One or more types of humectants such as Lietere/glycol, lactic acid) +3um (the amount added is usually 5 to 50% of the total composition)
30%); one or more inorganic powders such as kaolin, Merck, bentonite, titanium dioxide, and zinc oxide (the blending amount is usually 0 to 30%); Polymeric substances such as lipten, acrylic resin emulsion, vinyl acetate emulsion, etc. can be blended for the purpose of adjusting moldability, etc.).
本発明の貼付剤組成物は、上記成分を常法によって混合
することKより調製される。この貼付剤組成物は紙、織
布、不織布、プラスチックフィルム等の支持体に塗布し
、更に必要にょシ?リエチレンフィルム等の7エイシン
グを施して貼付剤とする。The patch composition of the present invention is prepared by mixing the above components in a conventional manner. This patch composition is applied to a support such as paper, woven fabric, non-woven fabric, plastic film, etc., and then applied as needed. Apply 7A coating such as polyethylene film to make a patch.
本発明貼付剤組成物は、多量の水分及び油成分を含有し
ているので、従来の膏体に比較して冷却効果が高いと共
に、有効成分の膏体からの放出性及び経皮吸収性に優れ
ている。また本発明貼付剤組成物は油成分を含有するが
、油性ゲル化剤の作用にエフ油成分のしみ出し、ダレ粘
着性の低下もなく疾患部位に貼付されて優れた効果を奏
する。Since the patch composition of the present invention contains a large amount of water and oil components, it has a higher cooling effect than conventional plasters, and also has improved release of active ingredients from the plaster and transdermal absorption. Are better. Furthermore, although the adhesive patch composition of the present invention contains an oil component, it can be applied to diseased areas and exhibits excellent effects without any oozing of the F oil component or decrease in sagging tackiness due to the action of the oil-based gelling agent.
次に実施例を挙げて本発明を更に詳しく説明する0
実施例1
下記の処方で、常法にエフ貼付剤組成物を調製し、これ
を湿布側膏体として不織布又はリント布の上に塗布し、
更に一すエチレンフイルムを施して湿布剤とした。Next, the present invention will be described in more detail with reference to Examples.0 Example 1 An F patch composition was prepared in a conventional manner according to the following formulation, and this was applied as a poultice on a nonwoven fabric or lint cloth. death,
A poultice was further coated with an ethylene film.
実施例1
■?リアクリル酸ソーダ 4.0(70ン
ピスSS9日本純薬工業■)
■?リアクリル酸 1.5(ゾユ
リマーAC−10H,日本綿薬工業■)■グリセリン
10.0■薬効成分 サリチル酸
グリコール 1.Oj−メントール
1.0■ミリスチン酸オクチルドデクル
3.0■?リソルベート80
2.0■硫酸アルミニウム
0・5■無水軽質シリカ 4・0
■水 残金 計
100.0%得られた湿布剤
は、有効成分の放出性、経皮吸収性及び粘着性に優れて
いた。Example 1 ■? Sodium lyacrylate 4.0 (70 mp SS9 Nippon Pure Chemical Industries ■) ■? Lyacrylic acid 1.5 (Zoyurimer AC-10H, Nippon Cotton Pharmaceutical Co., Ltd.) ■Glycerin
10.0■Medicinal ingredients Glycol salicylate 1. Oj-menthol
1.0■ Octyldodecyl myristate
3.0■? resolvate 80
2.0 ■ Aluminum sulfate
0.5■ Anhydrous light silica 4.0
■Water balance total
The poultice obtained at 100.0% had excellent release properties of the active ingredient, transdermal absorbability, and adhesiveness.
実施列2及び3
下記第1表に示す処方で常法にJ:り貼付剤組成物を調
製し、これを湿布側膏体として不織布又はリント布の上
に塗布し、更に?リエチレンフイルムを施して湿布剤と
した。Examples 2 and 3 A patch composition was prepared in a conventional manner according to the formulation shown in Table 1 below, and this was applied as a poultice on a nonwoven fabric or lint cloth, and then... A poultice was prepared by applying a polyethylene film.
以下余白
上で得た湿布剤について有効成分の放出性、経皮吸収性
及び粘着性を調べた。比較例として、実施例2.3から
ミリスチン酸オクチルドデシルを除い九もの(比較P1
1)及び実施例2.3からそれぞれ無水軽質シリカを除
いたもの(比較例2゜3)を用いた。The release properties of the active ingredient, transdermal absorption, and adhesiveness of the poultice obtained above were examined below. As a comparative example, nine samples were prepared from Example 2.3 except for octyldodecyl myristate (comparative P1).
1) and Example 2.3 from which anhydrous light silica was removed (Comparative Example 2.3).
伺放出性、経皮吸収性及び粘着性は次の如くして測定し
念〇
放 出 性:薬物保持槽、スクワラン処理ニトロセルa
−ス膜及び試料採取管付受器
からなる拡散セル装置を用いた。Release properties, transdermal absorption properties, and adhesion were measured as follows: Drug holding tank, squalane-treated Nitrocell a
- A diffusion cell device consisting of a gas membrane and a receptacle with a sample collection tube was used.
受器内をυノ酸生塩緩衝液で充念し た後、薬物保持槽中に各膏体を充填 し、受器内を攪拌しながら膜を介し て受器中に放出される薬物濃度を経 時的に測定した。Fill the container with υnoic acid raw salt buffer. After that, fill each paste into the drug holding tank. and pass through the membrane while stirring the inside of the receiver. The concentration of drug released into the receiver Measured over time.
経皮吸収性:白色家兎(15羽、各群5羽)の腹部を別
宅し、各ノ9ツゾ剤を貼付後、
経時的に採血して薬物の血中濃度を
測定した。Transdermal absorption: The abdomens of white rabbits (15 rabbits, 5 in each group) were placed in a separate house, each No9tsuzo drug was applied, and blood was collected over time to measure the drug concentration in the blood.
粘 着 性: JISタック試験法(球転法)により測
定した。Adhesion: Measured by JIS tack test method (ball rolling method).
結果を第1図、第2図及び第2表に示す。The results are shown in FIG. 1, FIG. 2, and Table 2.
第 2 表Table 2
第1図は本発明貼付側組成物の有効成分(サリチル酸グ
リコール)の放出性を示す図で7bJ)、第2図は同有
効成分の経皮吸収性を示す図でろる0以上
日
一 もコも東騒Q−1′l!5÷範回手続補正書(
自発)
昭和62年4 月138
1、 事件の表示
昭和62年 特 許 願第56047号2、発明の名
称
貼付剤組成物
3、 補正をする者
事件との関係 出願人
住所
名称 (091)花王株式会社
4、代理人
氏 名 (6870)弁理士 有 賀 三 娘 、−1
1住 所 同 上 皇二了。
氏 名 (7756)弁理士 高 野 登志雄 ’::
l’i・ 1
住 所 同 上 1−−二J6
、補正の対象
明細書の「発明の詳細な説明」の欄
7、補正の内容
(1)明細書中、第6頁第12行
「dj−カンフルト」とらるを
「dl−カンフル、ト」と訂正する。
(2)同、第7頁第3行
「5〜30%」とあるを
「5〜50%」と訂正する。Figure 1 shows the release properties of the active ingredient (glycol salicylate) of the adhesive composition of the present invention, and Figure 2 shows the transdermal absorption of the same active ingredient. Also Tosai Q-1'l! 5 ÷ standard procedural amendment (
Spontaneous) April 1982 138 1. Indication of the case 1988 Patent Application No. 56047 2. Name of the invention Patch composition 3. Relationship with the person making the amendment Applicant's address name (091) Kao Stocks Company 4, agent name (6870) Patent attorney Miko Ariga, -1
1 Address Same as above Koji Ryo. Name (7756) Patent Attorney Toshio Takano'::
l'i・1 Address Same as above 1--2J6
, Column 7 of "Detailed Description of the Invention" of the specification to be amended, contents of the amendment (1) In the specification, page 6, line 12, "dj-kanfurt" toraru is changed to "dl-kanfur, to". correct. (2) Same, page 7, line 3, "5-30%" is corrected to "5-50%."
Claims (1)
油成分2〜20重量%、水分30重量%以上、油性ゲル
化剤1〜15%及び有効成分を含有することを特徴とす
る貼付剤組成物。1. Contains 1 to 30% by weight of a water-soluble polymeric substance, 2 to 20% by weight of an oil component other than the active ingredient, 30% by weight or more of water, 1 to 15% of an oil-based gelling agent, and an active ingredient. Patch composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5604787A JPS63222113A (en) | 1987-03-11 | 1987-03-11 | Plaster composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5604787A JPS63222113A (en) | 1987-03-11 | 1987-03-11 | Plaster composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63222113A true JPS63222113A (en) | 1988-09-16 |
JPH0567127B2 JPH0567127B2 (en) | 1993-09-24 |
Family
ID=13016169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5604787A Granted JPS63222113A (en) | 1987-03-11 | 1987-03-11 | Plaster composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63222113A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996003131A1 (en) * | 1994-07-22 | 1996-02-08 | Sekisui Kagaku Kogyo Kabushiki Kaisha | Percutaneously absorbable preparation |
JP2006206540A (en) * | 2005-01-31 | 2006-08-10 | Hisamitsu Pharmaceut Co Inc | Sheet-like pack preparation and method for producing the same |
WO2008016077A1 (en) * | 2006-08-04 | 2008-02-07 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive preparation |
WO2020262057A1 (en) * | 2019-06-24 | 2020-12-30 | 帝國製薬株式会社 | Water-based adhesive patch |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54143517A (en) * | 1978-04-28 | 1979-11-08 | Hisamitsu Pharmaceut Co Inc | Novel poultice and its preparation |
JPS5742617A (en) * | 1980-08-27 | 1982-03-10 | Teikoku Seiyaku Kk | Flexible cataplasma |
JPS6067416A (en) * | 1983-09-17 | 1985-04-17 | デイナミ−ト・ノ−ベル・アクチエンゲゼルシヤフト | Gel or gel-containing composition and manufacture |
-
1987
- 1987-03-11 JP JP5604787A patent/JPS63222113A/en active Granted
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54143517A (en) * | 1978-04-28 | 1979-11-08 | Hisamitsu Pharmaceut Co Inc | Novel poultice and its preparation |
JPS5742617A (en) * | 1980-08-27 | 1982-03-10 | Teikoku Seiyaku Kk | Flexible cataplasma |
JPS6067416A (en) * | 1983-09-17 | 1985-04-17 | デイナミ−ト・ノ−ベル・アクチエンゲゼルシヤフト | Gel or gel-containing composition and manufacture |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996003131A1 (en) * | 1994-07-22 | 1996-02-08 | Sekisui Kagaku Kogyo Kabushiki Kaisha | Percutaneously absorbable preparation |
JP2006206540A (en) * | 2005-01-31 | 2006-08-10 | Hisamitsu Pharmaceut Co Inc | Sheet-like pack preparation and method for producing the same |
WO2008016077A1 (en) * | 2006-08-04 | 2008-02-07 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive preparation |
US8455376B2 (en) | 2006-08-04 | 2013-06-04 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive preparation |
JP5230423B2 (en) * | 2006-08-04 | 2013-07-10 | 久光製薬株式会社 | Patch |
US8809615B2 (en) | 2006-08-04 | 2014-08-19 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive preparation |
US9233184B2 (en) | 2006-08-04 | 2016-01-12 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive preparation |
WO2020262057A1 (en) * | 2019-06-24 | 2020-12-30 | 帝國製薬株式会社 | Water-based adhesive patch |
CN114007594A (en) * | 2019-06-24 | 2022-02-01 | 帝国制药株式会社 | Aqueous patch |
Also Published As
Publication number | Publication date |
---|---|
JPH0567127B2 (en) | 1993-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2000401C (en) | Percutaneous pharmaceutical preparation | |
US6207184B1 (en) | Hydrophilic adhesive masses | |
JPH03220120A (en) | Acrylic gel material and acrylic gel preparation | |
CN108553452A (en) | The adhesion preparation composition obtained by blending drug, organic solvent, lipophilicity matrix and powder | |
JPH0662401B2 (en) | Ketoprofen-containing patch | |
JPS5936608A (en) | Novel application drug | |
CA2041330C (en) | Percutaneously absorbable eperisone or tolperisone preparation | |
JP3276188B2 (en) | Patch and method for producing the same | |
JPS63222113A (en) | Plaster composition | |
JP5175041B2 (en) | Hydrophilic adhesive, hydrophilic external skin adhesive composition and hydrophilic patch using the same | |
JPS62148422A (en) | Therapeutical system | |
AU2004298930B2 (en) | Transdermal delivery system of hormones without penetration enhancers | |
JPH02115119A (en) | Automatic adhesive apparatus for percutaneous administration of effective component | |
JPH10265371A (en) | Transcutaneous absorption plaster | |
JPWO2012090322A1 (en) | Patch | |
AU2018348802A1 (en) | Transdermal therapeutic system for the transdermal administration of guanfacine comprising at least one additive | |
JP3193161B2 (en) | Transdermal absorption preparation | |
JP3427445B2 (en) | Cream | |
JPH10316560A (en) | Plaster | |
JP3406188B2 (en) | Patch | |
JPH03291218A (en) | Plaster | |
JPH11199519A (en) | Preparation for external use for skin | |
JP2017190309A (en) | Rivastigmine percutaneously absorbable preparation | |
JPH04321623A (en) | Plaster for dermal administration of estriol | |
JPH10316825A (en) | Adhesive composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |